JP2008545426A5 - - Google Patents

Download PDF

Info

Publication number
JP2008545426A5
JP2008545426A5 JP2008514187A JP2008514187A JP2008545426A5 JP 2008545426 A5 JP2008545426 A5 JP 2008545426A5 JP 2008514187 A JP2008514187 A JP 2008514187A JP 2008514187 A JP2008514187 A JP 2008514187A JP 2008545426 A5 JP2008545426 A5 JP 2008545426A5
Authority
JP
Japan
Prior art keywords
tcr
chain variable
variable region
seq
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008514187A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008545426A (ja
Filing date
Publication date
Priority claimed from GBGB0511124.0A external-priority patent/GB0511124D0/en
Application filed filed Critical
Publication of JP2008545426A publication Critical patent/JP2008545426A/ja
Publication of JP2008545426A5 publication Critical patent/JP2008545426A5/ja
Pending legal-status Critical Current

Links

JP2008514187A 2005-06-01 2006-05-31 高親和性メラン−at細胞レセプター Pending JP2008545426A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0511124.0A GB0511124D0 (en) 2005-06-01 2005-06-01 High affinity melan-a t cell receptors
PCT/GB2006/001980 WO2006129085A2 (en) 2005-06-01 2006-05-31 High affinity melan-a t cell receptors

Publications (2)

Publication Number Publication Date
JP2008545426A JP2008545426A (ja) 2008-12-18
JP2008545426A5 true JP2008545426A5 (cg-RX-API-DMAC7.html) 2009-07-09

Family

ID=34834931

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008514187A Pending JP2008545426A (ja) 2005-06-01 2006-05-31 高親和性メラン−at細胞レセプター

Country Status (12)

Country Link
US (1) US8217144B2 (cg-RX-API-DMAC7.html)
EP (1) EP1893642A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008545426A (cg-RX-API-DMAC7.html)
CN (1) CN101189261B (cg-RX-API-DMAC7.html)
AU (1) AU2006253941B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0611326A2 (cg-RX-API-DMAC7.html)
CA (1) CA2610786A1 (cg-RX-API-DMAC7.html)
EA (1) EA012507B1 (cg-RX-API-DMAC7.html)
GB (1) GB0511124D0 (cg-RX-API-DMAC7.html)
MX (1) MX2007014919A (cg-RX-API-DMAC7.html)
WO (1) WO2006129085A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200710009B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006036445A2 (en) 2004-09-24 2006-04-06 Trustees Of Dartmouth College Chimeric nk receptor and methods for treating cancer
WO2008039818A2 (en) * 2006-09-26 2008-04-03 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Modified t cell receptors and related materials and methods
EP2087000A2 (en) * 2006-09-29 2009-08-12 Immunocore Ltd. T cell therapies
WO2008042814A2 (en) * 2006-09-29 2008-04-10 California Institute Of Technology Mart-1 t cell receptors
GB0816096D0 (en) * 2008-09-04 2008-10-15 Medigene Ltd Diabetes t cell receptors
GB0911566D0 (en) 2009-07-03 2009-08-12 Immunocore Ltd T cell receptors
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
WO2011059836A2 (en) 2009-10-29 2011-05-19 Trustees Of Dartmouth College T cell receptor-deficient t cell compositions
US12492376B2 (en) 2009-10-29 2025-12-09 The Trustees Of Dartmouth College T-cell receptor-deficient T cell compositions
BR112013022557A2 (pt) * 2011-03-04 2017-08-01 Shire Human Genetic Therapies ligantes de peptídeo composições de polipeptídeo e métodos para uso dos mesmos
US9833476B2 (en) 2011-08-31 2017-12-05 The Trustees Of Dartmouth College NKP30 receptor targeted therapeutics
NZ702108A (en) 2012-05-03 2016-09-30 Hutchinson Fred Cancer Res Enhanced affinity t cell receptors and methods for making the same
CN104395344B (zh) 2012-05-07 2019-08-13 达特茅斯大学理事会 抗b7-h6抗体、融合蛋白及其使用方法
WO2014036562A2 (en) 2012-08-31 2014-03-06 University Of Virginia Patent Foundation Target peptides for immunotherapy and diagnostics
HK1212236A1 (en) 2012-09-05 2016-06-10 University Of Virginia Patent Foundation Target peptides for colorectal cancer therapy and diagnostics
JP6476182B2 (ja) 2013-11-22 2019-02-27 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ 改変された高親和性ヒトt細胞受容体
EP3137100B1 (en) 2014-04-15 2023-12-20 University Of Virginia Patent Foundation Isolated t cell receptors and methods of use therefor
EP2944652A1 (en) * 2014-05-13 2015-11-18 Technische Universität München Glypican-3-specific T-cell receptors and their uses for immunotherapy of hepatocellular carcinoma
WO2016014725A1 (en) * 2014-07-22 2016-01-28 The University Of Notre Dame Du Lac Molecular constructs and uses thereof
GB201417803D0 (en) * 2014-10-08 2014-11-19 Adaptimmune Ltd T cell receptors
GB201506642D0 (en) 2015-04-20 2015-06-03 Ucl Business Plc T cell receptor
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
GB201516277D0 (en) 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR libraries
GB201516272D0 (en) * 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR Libraries
JP7599819B2 (ja) 2016-06-02 2024-12-16 イムノコア リミテッド gp100特異的TCR-抗CD3 scFv融合タンパク質の投薬レジメン
GB201617714D0 (en) 2016-10-19 2016-11-30 Ucl Business Plc T Cell receptor
AU2018234830B2 (en) * 2017-03-15 2023-03-02 Fred Hutchinson Cancer Center High affinity MAGE-A1-specific TCRs and uses thereof
CN111032686B (zh) * 2017-06-30 2024-05-14 莱顿大学医学中心附属莱顿教学医院 血液恶性肿瘤的治疗
WO2019069125A1 (en) 2017-10-06 2019-04-11 Oslo Universitetssykehus Hf CHIMERIC ANTIGEN RECEPTORS
CN112646024B (zh) 2019-10-10 2023-03-24 香雪生命科学技术(广东)有限公司 一种识别kras突变的t细胞受体及其编码序列

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1421115E (pt) 2001-08-31 2005-07-29 Avidex Ltd Receptor de celulas t soluvel
US7751825B2 (en) 2002-06-27 2010-07-06 Qualcomm Incorporated Controlling geographic location information of devices operating in wireless communication systems
AU2003271904B2 (en) 2002-10-09 2009-03-05 Adaptimmune Limited Single chain recombinant T cell receptors
EP2048159B1 (en) * 2002-11-09 2014-01-01 Immunocore Ltd. T cell receptor display
JP2006523437A (ja) * 2002-12-03 2006-10-19 アヴィデックス リミテッド レセプター複合体
NZ550815A (en) 2004-05-19 2009-04-30 Immunocore Ltd Method of improving T cell receptors
WO2005113595A2 (en) * 2004-05-19 2005-12-01 Avidex Ltd High affinity ny-eso t cell receptor

Similar Documents

Publication Publication Date Title
JP2008535826A5 (cg-RX-API-DMAC7.html)
JP2006502741A5 (cg-RX-API-DMAC7.html)
JP2008509090A5 (cg-RX-API-DMAC7.html)
Wood et al. Crystal structure analysis of deamino-oxytocin: conformational flexibility and receptor binding
HRP20221021T1 (hr) T stanični receptori specifični za kompleks tumorskog antigena ny-eso-1 sa hla-a*02
CA2457652A1 (en) Soluble t cell receptor
US6620910B1 (en) Peptide compounds analogues of the glucagon-like peptide-1 (7-37)
JP2022502056A5 (cg-RX-API-DMAC7.html)
JP2006523437A5 (cg-RX-API-DMAC7.html)
CA2516702A1 (en) Modified t cell receptor linked by disulphide bond between constant domain cysteine residues
USRE42274E1 (en) Cyclic peptide CXCR4 antagonists
TW305846B (cg-RX-API-DMAC7.html)
HRP20220865T1 (hr) T stanični receptori
JP2011524420A5 (cg-RX-API-DMAC7.html)
HRP20230542T1 (hr) T stanični receptori
JP2013518115A5 (cg-RX-API-DMAC7.html)
HRP20231645T1 (hr) T stanični receptori
WO2001052880A1 (en) Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
BRPI9713914B1 (pt) Composition, use of the same, and, pharmaceutical composition
JP2020532496A5 (cg-RX-API-DMAC7.html)
MX2007014919A (es) Receptores de celulas t de melan-a de alta afinidad.
CN111183146A (zh) 高亲和力选择性结合cxcr4的缀合物及其使用方法
JP2023541366A5 (cg-RX-API-DMAC7.html)
Leprince et al. Structure–activity relationships of urotensin II and URP
JPS6396199A (ja) バソプレシン拮抗剤